CIT(A) dismissed Panacea Biotec's three appeals against ACIT penalty orders dated December 24, 2025 vide orders dated March 25, 2026.
The dismissed appeals relate to penalty for alleged under-reporting of income for AY 2017-18, 2020-21, and 2021-22, aggregating ~₹9.38 Crore demand.
Panacea Biotec considers the demand not maintainable and plans to file a further appeal with the next appellate authority.
Company states no material impact on financial, operational, or other activities is envisaged from this development.